Project Details
Description
ABSTRACT
Visual deficits stemming from retinal dysfunction are associated with Alzheimer’s Disease (AD).
As a result, assessment of retinal dysfunction may be a specific and non-invasive diagnostic tool
of AD at the earliest stages of pathology (Mahajan & Votruba, 2017). Two hallmarks of AD are
accumulation of senile plaques, composed mainly of amyloid-ß (Aß), and neurofibrillary tangles (NFT),
composed of hyperphosphorylated tau protein. In the retina of AD patients, the presence of senile plaques
and neurofibrillary tangles is limited, but there is extensive hyperphosphorylated tau throughout the inner
and outer plexiform layers (den Haan et al., 2018). We speculate that this hyperphosphorylated tau, alters
glucose metabolism and oxidative stress, leading to disruption of signaling in the retina and disease
progression. Indeed, metabolic diseases, diabetes and glaucoma that is not linked with intraocular
pressure, are associated with AD (Mancino et al., 2018). Hence, altered metabolism may be a critical
component of retinal dysfunction in AD. Still, the mechanisms underlying aging and AD related retinal
problems are poorly defined, which limits development of therapies .
Mitochondrial dysfunction is a critical component of aging and age-related neurodegeneration
including AD. In the Parent Grant (see Specific Aims on subsequent page), we are studying the structure
and dynamics of the synaptic ribbon in retinal cells, mainly bipolar cells and photoreceptors using “flash-
freeze” cryofixation electron (slam-freeze cryo-EM) microscopy, confocal microscopy with
electrophysiology, immunohistochemistry, and measuring oculomotor responses. This work is mainly
being done in zebrafish. In the present Supplement, we want to extend our experiments to study how
glucose metabolism and oxidative stress – elements associated with AD – impact synaptic transmission in
the retina focusing on mitochondria including mitophagy and structure and dynamics of the synaptic ribbon
in retinal cells, mainly bipolar cells and photoreceptors. We will essentially overlay the question of glucose
metabolism and oxidative stress on our on-going experiments. Critically, we will bring our highly refined
and quantitative approach to address the role of metabolism in retinal function. In Objective 1, we will
address how variations in glucose metabolism and oxidative stress impact the distribution and structure of
mitochondria and ribbon synapses using slam-freeze cryo-EM microscopy (Mses. Henry-Vanisko &
Akmentin & Dr. Joselevitch). This technique is central to the parent grant and will allow us to exam the
impact of glucose metabolism and oxidative in quantitative detail. In Objective 2, we will address how
NMDA receptors contribute to cell viability under conditions of altered glucose metabolism and oxidative
stress in the retina. NMDA receptors play critical roles in cell health in the retina and are strongly linked to
the neurodegeneration in AD (Wang & Reddy, 2017), and a putative treatment (neurosteroids) for
glaucoma and AD act through NMDA receptors (Ishikawa et al., 2018). For these experiments, we will
take advantage of NMDA receptor knock-outs we have generated to study NMDA receptor subunits in the
retina and the visual system as a whole (Mr. Zoodsma & Drs. Sirotkin & Joselevitch). Finally, in Objective
3, we will obtain fish lines that express various markers for mitochondria (e.g., express TMRE which
changes its fluorescence spectrum based on oxidation state)(Mandal et al., 2018)(Drs. Sirotkin &
Joselevitch). In the long term, these tools will allow us to ultimately expand our studies to whole animals
under chronic conditions.
Our major goal with the Supplement would be to establish the feasibility of our overall approach to
address glucose metabolism, oxidative stress, mitochondrial dynamics, mitophagy, and ribbon synapse
structure/dynamics in the retina. If we are successful, we would develop a new research program, in
collaboration with Dr. Howard Sirotkin, to continue to study glucose metabolism and oxidative stress in the
retina. We would envision submitting a new RO1, possibly independent of the Parent Grant, either to NEI
or NIA.
| Status | Finished |
|---|---|
| Effective start/end date | 04/1/17 → 03/31/21 |
Funding
- National Eye Institute: $1,770,178.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.